Type: Deck Idea
Format (legal 👍)
vinVintage
Approx. Value:
$67.07
Buy

0 Likes 0 Comments
Avg. CMC 2.41
Card Color Breakdown
Card Type Breakdown

Avatar: The Last Airbender
released on November 21, 2025!

Order now on CardKingdom Order now on TcgPlayer

Avatar: The Last Airbender
released on November 21, 2025!

Order now on CardKingdom Order now on TcgPlayer
Main Deck - 60 cards, 22 distinct
Sort by:
:
Name  Ed. Price Type Cost
Rarity Color
Creature (24)
4 Agadeem Occultist
$0.53
Creature - Human Shaman Ally
2 Bala Ged Thief
$0.30
Creature - Human Rogue Ally
4 Bojuka Brigand
$0.07
Creature - Human Warrior Ally
4 Hada Freeblade
$0.49
Creature - Human Soldier Ally
2 Hagra Diabolist
$0.33
Creature - Ogre Shaman Ally
4 Kazandu Blademaster
$0.36
Creature - Human Soldier Ally
4 Ondu Cleric
$0.74
Creature - Kor Cleric Ally
Instant (6)
2 Dark Ritual
$2.65
Instant
1 Surgical Extraction
$0.80
Instant
3 Unmake
$0.45
Instant
Artifact (4)
1 Aether Vial
$2.84
Artifact
1 Conjurer's Closet
$3.39
Artifact
1 Sol Ring
$1.20
Artifact
1 Tablet of the Guilds
$0.21
Artifact
Enchantment (6)
2 Journey to Nowhere
$0.30
Enchantment
2 Oblivion Ring
$0.13
Enchantment
2 Oubliette
$1.51
Enchantment
Land (20)
1 Cavern of Souls
$36.10
Land
1 Isolated Chapel
$0.48
Land
2 Orzhov Guildgate
$0.19
Land - Gate
8 Plains
$0.07
Basic Land - Plains
8 Swamp
$0.07
Basic Land - Swamp
Sideboard - 0 cards, 0 distinct
Sort by:
:
No cards here. :(

Notes
 
I have done B/W allies once before (Suture, at 1-3), and I have three times done exile as a strong piece of the deck in B/W, once with rebels. However, I have not combined some exile with allies before in B/W, and I wanted to give it a try. The deck has 24 creatures, all allies, a little help with mana and casting, and some additional life gaining. The creatures have a 4/12/4/2/2 curve that averages 2.42, which is not bad for allies and gives the Æther Vial a clear early target at the 2-spot. The other cards are a little cheaper, on average, bringing the final curve to 9/15/11/2/3 for a 2.38 average.
Comments
    No comments yet.